About the RoleThis is a zero-to-one growth leadership role at an early-stage healthtech company building AI-powered reimbursement automation for interventional specialties. You will work directly with the founding team to define the go-to-market motion for medical device OEMs, shaping revenue strategy, key partnerships, and product-market fit from the ground up.
What You'll Do- Source OEM leads and open relationships across market access and reimbursement teams.
- Run discovery sessions to map OEM workflows and identify product fit opportunities.
- Develop a clear ideal customer profile and build a repeatable sales playbook.
- Own OEM accounts end-to-end, from first call through signed contract and ongoing relationship management.
- Attend key industry conferences and build community partnerships to expand reach.
- Research opportunities across procurement, market access intelligence, and reimbursement infrastructure.
- Partner with cross-functional teams to translate OEM needs into product and commercialization priorities.
What We're Looking For- 4 to 7 years of experience working within medical device companies, with direct exposure to reimbursement or market access functions.
- Experience in health economics and outcomes research (HEOR) that satisfies reimbursement and market-access requirements.
- Deep understanding of the OEM ecosystem, including decision-making, budgeting, and how reimbursement risk affects commercial outcomes.
- Background in endovascular, cardiovascular, or interventional radiology specialties is strongly preferred.
- Cross-functional exposure spanning market access, reimbursement, supply chain, and R&D.
- Comfortable actively incorporating AI tools into your day-to-day workflow.
- Familiarity with the US healthcare system and payor landscape.
- Willingness to travel to conferences and attend in-person meetings as needed.
Compensation & BenefitsBase salary range:
$130,000 to $200,000 USD annually, plus meaningful equity. Visa sponsorship is not available for this role.
LocationHybrid, based in
New York City, NY. In-person presence is expected as needed, along with some travel to industry conferences.
